111 related articles for article (PubMed ID: 30895984)
1. Dehydrocurvularin is a potent antineoplastic agent irreversibly blocking ATP-citrate lyase: evidence from chemoproteomics.
Deng Z; Wong NK; Guo Z; Zou K; Xiao Y; Zhou Y
Chem Commun (Camb); 2019 Apr; 55(29):4194-4197. PubMed ID: 30895984
[TBL] [Abstract][Full Text] [Related]
2. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
3. ATP citrate lyase (ACLY): a promising target for cancer prevention and treatment.
Khwairakpam AD; Shyamananda MS; Sailo BL; Rathnakaram SR; Padmavathi G; Kotoky J; Kunnumakkara AB
Curr Drug Targets; 2015; 16(2):156-63. PubMed ID: 25537655
[TBL] [Abstract][Full Text] [Related]
4. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Taguchi R; Soga T; Seimiya H
Am J Pathol; 2013 May; 182(5):1800-10. PubMed ID: 23506848
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.
Koerner SK; Hanai JI; Bai S; Jernigan FE; Oki M; Komaba C; Shuto E; Sukhatme VP; Sun L
Eur J Med Chem; 2017 Jan; 126():920-928. PubMed ID: 27997879
[TBL] [Abstract][Full Text] [Related]
7. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
[TBL] [Abstract][Full Text] [Related]
8. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
Burke AC; Huff MW
Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
[TBL] [Abstract][Full Text] [Related]
9. Targeting mitochondrial citrate transport in breast cancer cell lines.
Ozkaya AB; Ak H; Atay S; Aydin HH
Anticancer Agents Med Chem; 2015; 15(3):374-81. PubMed ID: 25511512
[TBL] [Abstract][Full Text] [Related]
10. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.
Xin M; Qiao Z; Li J; Liu J; Song S; Zhao X; Miao P; Tang T; Wang L; Liu W; Yang X; Dai K; Huang G
Oncotarget; 2016 Jul; 7(28):44252-44265. PubMed ID: 27317765
[TBL] [Abstract][Full Text] [Related]
11. ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.
Gribble AD; Dolle RE; Shaw A; McNair D; Novelli R; Novelli CE; Slingsby BP; Shah VP; Tew D; Saxty BA; Allen M; Groot PH; Pearce N; Yates J
J Med Chem; 1996 Aug; 39(18):3569-84. PubMed ID: 8784456
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.
Zang Y; Tai L; Hu Y; Wang Y; Sun H; Wen X; Yuan H; Dai L
J Chem Inf Model; 2022 Jun; 62(12):3123-3132. PubMed ID: 35679529
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells.
Migita T; Okabe S; Ikeda K; Igarashi S; Sugawara S; Tomida A; Soga T; Taguchi R; Seimiya H
Int J Cancer; 2014 Jul; 135(1):37-47. PubMed ID: 24310723
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ATP citrate lyase (ACLY) protects airway epithelia from PM
Fu Y; Lu R; Cui J; Sun H; Yang H; Meng Q; Wu S; Aschner M; Li X; Chen R
Ecotoxicol Environ Saf; 2019 Jan; 167():309-316. PubMed ID: 30343145
[TBL] [Abstract][Full Text] [Related]
15. Energy deregulation: licensing tumors to grow.
Garber K
Science; 2006 May; 312(5777):1158-9. PubMed ID: 16728625
[No Abstract] [Full Text] [Related]
16. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth.
Gao Y; Islam MS; Tian J; Lui VW; Xiao D
Cancer Lett; 2014 Jul; 349(1):15-25. PubMed ID: 24690568
[TBL] [Abstract][Full Text] [Related]
17. The vital role of ATP citrate lyase in chronic diseases.
Khwairakpam AD; Banik K; Girisa S; Shabnam B; Shakibaei M; Fan L; Arfuso F; Monisha J; Wang H; Mao X; Sethi G; Kunnumakkara AB
J Mol Med (Berl); 2020 Jan; 98(1):71-95. PubMed ID: 31858156
[TBL] [Abstract][Full Text] [Related]
18. Two New Oleanane-Triterpenoid Saponins from Clinopodium gracile.
Zhao T; Liu YN; Sun XY; Li JY; Lei C; Hou AJ
Chem Biodivers; 2021 Nov; 18(11):e2100672. PubMed ID: 34519420
[TBL] [Abstract][Full Text] [Related]
19. 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors.
Li JJ; Wang H; Tino JA; Robl JA; Herpin TF; Lawrence RM; Biller S; Jamil H; Ponticiello R; Chen L; Chu CH; Flynn N; Cheng D; Zhao R; Chen B; Schnur D; Obermeier MT; Sasseville V; Padmanabha R; Pike K; Harrity T
Bioorg Med Chem Lett; 2007 Jun; 17(11):3208-11. PubMed ID: 17383874
[TBL] [Abstract][Full Text] [Related]
20. Discovery of furan carboxylate derivatives as novel inhibitors of ATP-citrate lyase via virtual high-throughput screening.
Jernigan FE; Hanai JI; Sukhatme VP; Sun L
Bioorg Med Chem Lett; 2017 Feb; 27(4):929-935. PubMed ID: 28129980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
